Experts say that people with chronic conditions that affect the immune system, such as lupus and diabetes, are at a higher risk of developing severe complications from coronavirus. Here’s what you need to know about immunocompromised patients and coronavirus COVID-19.
In light of a flu season that has unofficially become “flu-and-coronavirus season”, there’s a lot of buzz around those who are most at risk for severe complications from coronaviruses: specifically, the elderly and those who are immunocompromised. But what does it actually mean to be immunocompromised? And how does having a compromised immune system play out with coronavirus COVID-19? Here, experts explain everything you need to know about protecting people with immune deficiencies amid the coronavirus outbreak.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.
